Patterns and Trends in Human Papillomavirus-Related Diseases in Central and Eastern Europe and Central Asia

Vaccine

Volumn 31, Issue S7, 2013, Pages

  Bray, Freddie ^a   Lortet Tieulent, Joannie ^a   Znaor, Ariana ^b,c   Brotons, Maria ^d   Poljak, Mario ^e   Arbyn, Marc ^f,g  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b CROATIAN NATIONAL INSTITUTE OF PUBLIC HEALTH   (Croatia)

^c UNIVERSITY OF ZAGREB   (Croatia)

^d CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^e UNIVERSITY OF LJUBLJANA   (Slovenia)

^f SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

^g UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Central Asia; Central Europe; Cervix; Eastern Europe; HPV; Incidence; Mortality; Neoplasms; Screening; Trends

Indexed keywords

WART VIRUS VACCINE;

ARMENIA; ASIA; AZERBAIJAN; BOSNIA AND HERZEGOVINA; BULGARIA; CANCER IMMUNIZATION; CANCER SCREENING; CONDYLOMA ACUMINATUM; CROATIA; CZECH REPUBLIC; EASTERN EUROPE; ESTONIA; HEAD AND NECK CANCER; HUMAN; HUNGARY; INCIDENCE; KAZAKHSTAN; KYRGYZSTAN; LATVIA; LITHUANIA; MOLDOVA; MONTENEGRO (REPUBLIC); NONHUMAN; PAPILLOMATOSIS; PAPILLOMAVIRUS INFECTION; POLAND; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; ROMANIA; RUSSIAN FEDERATION; SERBIA; SLOVAKIA; SLOVENIA; TAJIKISTAN; TREND STUDY; TURKMENISTAN; UKRAINE; UTERINE CERVIX CANCER; UZBEKISTAN; WART VIRUS;

CENTRAL ASIA; CENTRAL EUROPE; CERVIX; EASTERN EUROPE; HPV; INCIDENCE; MORTALITY; NEOPLASMS; SCREENING; TRENDS;

ASIA, CENTRAL; EUROPE, EASTERN; HUMANS; INCIDENCE; NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; SURVIVAL ANALYSIS;

EID: 84890206009     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.02.071     Document Type: Review

References (39)

1. Arbyn M., Castellsague X., de Sanjose S., Bruni L., Saraiya M., Bray F., et al. Worldwide burden of cervical cancer in 2008. Ann Oncol 2011, 22(12):2675-2686.
2. Rogovskaya S.I., Shabalova I.P., Mikheeva I.V., Minkina G.N., Podzolkova N.M., Shipulina O.Y., et al. Human Papillomavirus Prevalence and Type-Distribution, Cervical Cancer Screening Practices and Current Status of Vaccination Implementation in Russian Federation, the Western Countries of the Former Soviet Union, Caucasus Region and Central Asia. Vaccine 2013, 31S:H46-H58.
3. Poljak M., Seme K., Maver P.J., Kocjan B.J., Cuschieri K.S., Rogovskaya S.I., et al. Human Papillomavirus Prevalence and Type-Distribution. Cervical Cancer Screening Practices and Current Status of Vaccination Implementation in Central and Eastern Europe. Vaccine 2013, 31S:H59-H70.
4. Ferlay J., Shin H.R., Bray F., Forman D., Mathers C., Parkin D.M. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010, 127(12). 2893-917.
5. GLOBOCAN data sources and methods. Available at: [last accessed April 2013]. http://globocan.iarc.fr/DataSource_and_methods.asp.
6. Ferlay J, Parkin DM, Curado MP, Bray F, Edwards B, Forman D. Cancer Incidence in Five Continents, Volumes I to IX: IARC CancerBase No. 9 [internet]. Lyon, France: International Agency for Research on Cancer; 2010. Available at: http://ci5.iarc.fr [last accessed April 2013].
7. WHO mortality database. Available at: [last accessed April 2013]. http://www.who.int/healthinfo/statistics/mortality/en/index.html.
8. Doll R., Payne P., Waterhouse J.A.H. Cancer Incidence in Five Continents. Vol. I. 1966, IARC, Geneva.
9. Holford T.R. Statistical methods in genetic epidemiology. Stat Methods Med Res 2001, 10(1):1-82.
10. Rutherford M.J., Lambert P.C., Thompson J.R. Age-period-cohort modelling. Stata Journal 2010, 10:602-627.
11. StataCorp. Stata Statistical Software. College Station, TX: StataCorp LP; 2009.
12. Klavs I., Grgic-Vitek M. The burden of genital warts in Slovenia: results from a national probability sample survey. Euro Surveill 2008, 13(45):ii.
13. Fenton K.A., Korovessis C., Johnson A.M., McCadden A., McManus S., Wellings K., et al. Sexual behaviour in Britain: reported sexually transmitted infections and prevalent genital Chlamydia trachomatis infection. Lancet 2001, 358(9296):1851-1854.
14. Kjaer S.K., Tran T.N., Sparen P., Tryggvadottir L., Munk C., Dasbach E., et al. The burden of genital warts: a study of nearly 70,000 women from the general female population in the 4 Nordic countries. J Infect Dis 2007, 196(10):1447-1454.
15. Kambiè V., Gale N. Epithelial Hyperplastic Lesions of the Larynx. 1995, Elsevier, Amsterdam.
16. Lindeberg H., Elbrond O. Laryngeal papillomas: the epidemiology in a Danish subpopulation 1965-1984. Clin Otolaryngol Allied Sci 1990, 15(2):125-131.
17. Silverberg M.J., Thorsen P., Lindeberg H., Grant L.A., Shah K.V. Condyloma in pregnancy is strongly predictive of juvenile-onset recurrent respiratory papillomatosis. Obstet Gynecol 2003, 101(4):645-652.
18. Bray F., Loos A.H., McCarron P., Weiderpass E., Arbyn M., Moller H., et al. Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening. Cancer Epidemiol Biomarkers Prev 2005, 14(3):677-686.
19. Hill G.B., Adelstein A.M. Cohort mortality from carcinoma of the cervix. Lancet 1967, 2(7516):605-606.
20. Bruni L., Diaz M., Castellsague X., Ferrer E., Bosch F.X., de Sanjosé S. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis 2010, 202(12):1789-1799.
21. Maucort-Boulch D., Franceschi S., Plummer M. International correlation between human papillomavirus prevalence and cervical cancer incidence. Cancer Epidemiol Biomarkers Prev 2008, 17(3):717-720.
22. Cervical carcinoma and reproductive factors: collaborative reanalysis of individual data on 16,563 women with cervical carcinoma and 33,542 women without cervical carcinoma from 25 epidemiological studies. Int J Cancer 2006;119(5):1108-24.
23. Appleby P., Beral V., Berrington de G.A., Colin D., Franceschi S., Goodhill A., et al. Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies. Lancet 2007, 370(9599):1609-1621.
24. International Agency for Research on Cancer. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Volume 100 - Part B. Geneva: WHO; 2012.
25. Appleby P., Beral V., Berrington de G.A., Colin D., Franceschi S., Goodill A., et al. Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies. Int J Cancer 2006, 118(6):1481-1495.
26. Hammarstedt L., Dahlstrand H., Lindquist D., Onelov L., Ryott M., Luo J., et al. The incidence of tonsillar cancer in Sweden is increasing. Acta Otolaryngol 2007, 127(9):988-992.
27. Schantz S.P., Yu G.P. Head and neck cancer incidence trends in young Americans, 1973-1997, with a special analysis for tongue cancer. Arch Otolaryngol Head Neck Surg 2002, 128(3):268-274.
28. Shiboski C.H., Schmidt B.L., Jordan R.C. Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20-44 years. Cancer 2005, 103(9):1843-1849.
29. Sturgis E.M., Cinciripini P.M. Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers?. Cancer 2007, 110(7):1429-1435.
30. Franceschi S., Munoz N., Bosch X.F., Snijders P.J., Walboomers J.M. Human papillomavirus and cancers of the upper aerodigestive tract: a review of epidemiological and experimental evidence. Cancer Epidemiol Biomarkers Prev 1996, 5(7):567-575.
31. Chaturvedi A.K., Engels E.A., Pfeiffer R.M., Hernandez B.Y., Xiao W., Kim E., et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 2011, 29(32):4294-4301.
32. Arbyn M., Raifu A.O., Weiderpass E., Bray F., Anttila A. Trends of cervical cancer mortality in the member states of the European Union. Eur J Cancer 2009, 45(15):2640-2648.
33. Arbyn M., Antoine J., Magi M., Smailyte G., Stengrevics A., Suteu O., et al. Trends in cervical cancer incidence and mortality in the Baltic countries. Bulgaria and Romania. Int J Cancer 2011, 128(8):1899-1907.
34. Loos A.H., Bray F., McCarron P., Weiderpass E., Hakama M., Parkin D.M. Sheep and goats: separating cervix and corpus uteri from imprecisely coded uterine cancer deaths, for studies of geographical and temporal variations in mortality. Eur J Cancer 2004, 40(18):2794-2803.
35. Arbyn M., Geys H. Trend of cervical cancer mortality in Belgium (1954-1994): tentative solution for the certification problem of unspecified uterine cancer. Int J Cancer 2002, 102(6):649-654.
36. International Agency for Research on Cancer. Cervix cancer screening. Lyon: IARC Press; 2004.
37. Berkhof J., Bogaards J.A., Demirel E., Diaz M., Sharma M., Kim J.J. Cost-Effectiveness of Cervical Cancer Prevention in Central and Eastern Europe and Central Asia. Vaccine 2013, 31S:H71-H79.
38. European Commission. European Guidelines for Quality Assurance in Cervical Cancer Screening. 2nd edition. Luxembourg: Office for Official Publications of the European Communities. 2008.
39. Arbyn M., Anttila A., Jordan J., Ronco G., Schenck U., Segnan N., et al. European Guidelines for Quality Assurance in Cervical Cancer Screening. Second edition--summary document. Ann Oncol 2010, 21(3):448-458.